Combination Drug Therapy for Patients with Intractable Ventricular Tachycardia Associated with Right Ventricular Cardiomyopathy

Abstract

In our experience, combination drug therapy is an effective treatment strategy for patients with ventricular tachycardia refractory to monotherapy and, in some cases, ablation. In addition, flecainide appears to be safe and effective for those with RV cardiomyopathy without significant left ventricular dysfunction.